InsiderClue
Insiders · Profile

Powl Brian T.

Chief Commercial Officer at Kura Oncology · Chief Commercial Officer at FATE THERAPEUTICS. Filing since 5 Jul 2023. CIK 0001934232

KURA Kura Oncology, Inc. Chief Commercial Officer · 9 trades FATE FATE THERAPEUTICS INC Chief Commercial Officer · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
KURA Kura Oncology, Inc.
29 Sep 2026
Chief Commercial Officer
Sold at will
15,430
$165.85K
10.1%
KURA Kura Oncology, Inc.
28 Sep 2026
Chief Commercial Officer
Sold at will
17,020
$179.18K
10.1%
KURA Kura Oncology, Inc.
21 Aug 2026
Chief Commercial Officer
Sold on a plan
4,345
$51.66K
2.5%
KURA Kura Oncology, Inc.
21 May 2026
Chief Commercial Officer
Sold on a plan
10,000
$110.00K
5.4%
KURA Kura Oncology, Inc.
19 May 2026
Chief Commercial Officer
Sold on a plan
339
$3.12K
0.2%
KURA Kura Oncology, Inc.
27 Jan 2026
Chief Commercial Officer
Sold at will
6,414
$54.27K
3.4%
KURA Kura Oncology, Inc.
14 Nov 2025
Chief Commercial Officer
Sold at will
8,887
$99.33K
6.0%
KURA Kura Oncology, Inc.
29 Sep 2025
Chief Commercial Officer
Sold at will
8,891
$79.51K
8.2%
KURA Kura Oncology, Inc.
28 Jan 2025
Chief Commercial Officer
Sold at will
1,583
$12.46K
2.6%
FATE FATE THERAPEUTICS INC
5 Jul 2023
Chief Commercial Officer
Sold at will
3,854
$18.77K
8.6%
10 decisions on file.